Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Gottlieb

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
International Journal of Molecular Sciences|August 28, 2025
HAT-PCR Enables Sensitive Quantification of Minimal Residual Disease in Chronic Lymphocytic Leukemia and MyelomaElizabeth Hughes, Sue Latham, Bryone Kuss, et al.
JMIR Research Protocols|September 23, 2025
Home-Based Exercise to Improve Functional Outcomes in Veterans With a Recently Healed Diabetic Foot Ulcer: Protocol for a Pilot Randomized Controlled TrialGwen L Robinson, Jake Drumheller, Alison D Lydecker, et al.
Cancer Medicine|April 26, 2016
Adherence to cancer screening guidelines in Australian survivors of allogeneic blood and marrow transplantation (BMT)Gemma Dyer, Stephen R Larsen, Nicole Gilroy, et al.
Cancer Medicine|October 30, 2016
Epidemiology of complementary and alternative medicine therapy use in allogeneic hematopoietic stem cell transplant survivorship patients in AustraliaJulian Lindsay, Masrura Kabir, Nicole Gilroy, et al.
Clinical Nursing Research|June 17, 2023
Decisional Regret in Long-Term Australian Allogeneic Hematopoietic Stem Cell Transplantation Survivors: A Cross-Sectional SurveyGemma McErlean, Caley Tapp, Lisa Brice, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|October 31, 2020
Fear of cancer recurrence following allogeneic haematopoietic stem cell transplantation (HSCT) for haematological malignancy: A cross-sectional studyLisa Brice, Gemma McErlean, Caroline Donovan, et al.
British Journal of Haematology|December 16, 2021
Zanubrutinib for treatment-naïve and relapsed/refractory chronic lymphocytic leukaemia: long-term follow-up of the phase I/II AU-003 studyGavin Cull, Jan A Burger, Stephen Opat, et al.
Frontiers in Cellular and Infection Microbiology|July 3, 2020
Whole-Genome Approach to Assessing Human Cytomegalovirus Dynamics in Transplant Patients Undergoing Antiviral TherapyNicolás M Suárez, Emily Blyth, Kathy Li, et al.
Bone Marrow Transplantation|April 20, 2022
The improvement in overall survival from unrelated donor transplantation in Australia and New Zealand is driven by a reduction in non-relapse mortality: A study from the ABMTRRDavid Kliman, Steven Tran, Glen Kennedy, et al.
Leukemia & Lymphoma|January 20, 2022
Low utility of the H-Score and HLH-2004 criteria to identify patients with secondary hemophagocytic lymphohistiocytosis after CAR-T cell therapy for relapsed/refractory diffuse large B-Cell lymphomaDong Won Kim, Ali Bukhari, Forat Lutfi, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
International Journal of Molecular Sciences|August 28, 2025
HAT-PCR Enables Sensitive Quantification of Minimal Residual Disease in Chronic Lymphocytic Leukemia and MyelomaElizabeth Hughes, Sue Latham, Bryone Kuss, et al.
JMIR Research Protocols|September 23, 2025
Home-Based Exercise to Improve Functional Outcomes in Veterans With a Recently Healed Diabetic Foot Ulcer: Protocol for a Pilot Randomized Controlled TrialGwen L Robinson, Jake Drumheller, Alison D Lydecker, et al.
Cancer Medicine|April 26, 2016
Adherence to cancer screening guidelines in Australian survivors of allogeneic blood and marrow transplantation (BMT)Gemma Dyer, Stephen R Larsen, Nicole Gilroy, et al.
Cancer Medicine|October 30, 2016
Epidemiology of complementary and alternative medicine therapy use in allogeneic hematopoietic stem cell transplant survivorship patients in AustraliaJulian Lindsay, Masrura Kabir, Nicole Gilroy, et al.
Clinical Nursing Research|June 17, 2023
Decisional Regret in Long-Term Australian Allogeneic Hematopoietic Stem Cell Transplantation Survivors: A Cross-Sectional SurveyGemma McErlean, Caley Tapp, Lisa Brice, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|October 31, 2020
Fear of cancer recurrence following allogeneic haematopoietic stem cell transplantation (HSCT) for haematological malignancy: A cross-sectional studyLisa Brice, Gemma McErlean, Caroline Donovan, et al.
British Journal of Haematology|December 16, 2021
Zanubrutinib for treatment-naïve and relapsed/refractory chronic lymphocytic leukaemia: long-term follow-up of the phase I/II AU-003 studyGavin Cull, Jan A Burger, Stephen Opat, et al.
Frontiers in Cellular and Infection Microbiology|July 3, 2020
Whole-Genome Approach to Assessing Human Cytomegalovirus Dynamics in Transplant Patients Undergoing Antiviral TherapyNicolás M Suárez, Emily Blyth, Kathy Li, et al.
Bone Marrow Transplantation|April 20, 2022
The improvement in overall survival from unrelated donor transplantation in Australia and New Zealand is driven by a reduction in non-relapse mortality: A study from the ABMTRRDavid Kliman, Steven Tran, Glen Kennedy, et al.
Leukemia & Lymphoma|January 20, 2022
Low utility of the H-Score and HLH-2004 criteria to identify patients with secondary hemophagocytic lymphohistiocytosis after CAR-T cell therapy for relapsed/refractory diffuse large B-Cell lymphomaDong Won Kim, Ali Bukhari, Forat Lutfi, et al.
Pageof 9